How VA Rates Pseudofolliculitis Barbae
The Department of Veterans Affairs (VA) rating schedule in the Code of Federal Regulations (CFR), section 4.118, does not list pseudofolliculitis barbae (PFB, or razor bumps) by name. For an unlisted condition, VA may select a closely related diagnostic code (DC) by analogy under 38 CFR 4.20 and build the code under 38 CFR 4.27. The code and evaluation depend on the findings in the individual record.
The General Rating Formula for the Skin applies to DC 7806, for dermatitis or eczema, and the other codes named in that formula. DC 7800 covers disfigurement of the head, face, or neck. DC 7804 covers unstable or painful scars without limiting that code to the head, face, or neck. DC 7828 covers acne. These are examples of listed codes to examine when reading the schedule and do not state that VA assigns any one of them to PFB.
Start with the code VA selected if you have a decision letter. Then compare the documented skin findings with the criteria for that code. The formula below measures characteristic lesion extent or required systemic therapy. The scar provisions instead describe disfigurement, unstable scars, and painful scars. Reading a percentage from the dermatitis table without first identifying the selected code would skip the analogy decision required for an unlisted condition.
Why 38 CFR 4.118 Lists No PFB Code
The text of 38 CFR 4.118 does not list pseudofolliculitis barbae by name. 38 CFR 4.20 addresses what happens when a condition is unlisted: it permits a rating under a closely related disease or injury. The affected functions, anatomical location, and symptoms must be closely analogous. The regulation also says to avoid conjectural analogies and analogous ratings for conditions of doubtful diagnosis or conditions not fully supported by clinical and laboratory findings.
That rule makes the medical findings relevant to code selection. A description of bumps alone does not establish which listed code best matches a particular record. A record describing characteristic lesions raises a different comparison with the schedule from one describing a scar's pain, instability, or disfigurement. Those are comparisons to the published criteria. They do not predict the code VA would choose.
38 CFR 4.27 explains the numbering for an unlisted condition rated by analogy. VA builds the diagnostic code using digits from the part of the schedule that most closely identifies the body part or system involved. The last two digits are 99 for an unlisted condition. This numbering rule does not supply a single PFB code or choose between the skin findings described in 38 CFR 4.118.
If you are reading a decision letter, distinguish its assigned code from the listed code used for comparison. The built-up number identifies how an unlisted condition was classified. The cited rating criteria explain what findings support the evaluation. Compare both with the findings recorded in the letter rather than treating the name PFB as a percentage on its own.
Dermatitis Formula Tiers
The General Rating Formula for the Skin gives the following tiers for the diagnostic codes it names, including DC 7806. Each tier is based on at least one of its stated alternatives. These are the formula's criteria. The formula does not assign a fixed rating table to PFB.
| Rating | Lesion extent | Systemic therapy |
|---|---|---|
| 60% | Characteristic lesions on more than 40% of the entire body or more than 40% of exposed areas. | Constant or near-constant systemic therapy required over the past 12 months. |
| 30% | Characteristic lesions on 20% to 40% of the entire body or 20% to 40% of exposed areas. | Systemic therapy required for a total of 6 weeks or more, but not constantly, over the past 12 months. |
| 10% | Characteristic lesions on at least 5% but less than 20% of the entire body or of exposed areas. | Intermittent systemic therapy required for a total of less than 6 weeks over the past 12 months. |
| 0% | Characteristic lesions on less than 5% of the entire body or of exposed areas. | No more than topical therapy required over the past 12 months. Both the lesion and therapy conditions in this row apply. |
The lesion column offers an entire-body measure and an exposed-area measure. At the compensable tiers shown above, the formula also offers a systemic-therapy alternative. The zero-percent tier is worded differently: it requires both the stated lesion extent and no more than topical therapy. Keep those connectors in view when you compare a medical finding with a table row.
38 CFR 4.118(a) defines systemic therapy by how it is administered: through a route other than the skin, such as orally, by injection, by suppository, or intranasally. It defines topical therapy as treatment administered through the skin. The formula lists corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, psoralen with long-wave ultraviolet-A light (PUVA), and other immunosuppressive drugs among its systemic-therapy examples. Its wording requires attention to the route and duration of treatment, rather than a treatment name alone.
For a formula comparison, look for the percentage of the entire body or exposed area affected and the treatment route recorded in the medical findings. If systemic therapy is documented, compare its required duration with the period stated in the applicable row. A finding about extent answers the lesion question. A finding about how long treatment was required answers the therapy question. Neither finding by itself tells you that VA selected the dermatitis formula for PFB.
DC 7806 directs VA to evaluate dermatitis or eczema under this formula. Other named codes also use it, but the presence of DC 7806 in the schedule does not turn PFB into dermatitis. For a separate guide to the listed conditions, see eczema and dermatitis VA rating.
Scars and Disfigurement Codes
38 CFR 4.118 provides separate criteria for disfigurement of the head, face, or neck under DC 7800 and for unstable or painful scars under DC 7804. The General Rating Formula for the Skin also says to rate as disfigurement under DC 7800 or as scars under DC 7801, 7802, 7804, or 7805, depending upon the predominant disability. That instruction does not apply to DC 7824. It is an instruction within the formula and does not designate PFB's diagnostic code.
DC 7800 addresses a particular location: the head, face, or neck. Its tiers use visible or palpable tissue loss with gross distortion or asymmetry of specified features, or a count of characteristics of disfigurement. The features named in the code are the nose, chin, forehead, eyes including eyelids, ears, cheeks, and lips.
| Rating | Criterion |
|---|---|
| 80% | Visible or palpable tissue loss and gross distortion or asymmetry of three or more features or paired sets of features, or six or more characteristics of disfigurement. |
| 50% | Visible or palpable tissue loss and gross distortion or asymmetry of two features or paired sets of features, or four or five characteristics of disfigurement. |
| 30% | Visible or palpable tissue loss and gross distortion or asymmetry of one feature or paired set of features, or two or three characteristics of disfigurement. |
| 10% | One characteristic of disfigurement. |
Note 1 to DC 7800 defines the eight characteristics of disfigurement. They describe measurable scar length, width, texture, color, contour, adherence, and changes beneath or within the skin:
- A scar 5 or more inches (13 or more centimeters) long.
- A scar at least one-quarter inch (0.6 centimeters) wide at its widest part.
- A scar surface contour elevated or depressed on palpation.
- A scar adherent to underlying tissue.
- Skin that is lighter or darker in an area exceeding six square inches (39 square centimeters).
- Abnormal skin texture in an area exceeding six square inches (39 square centimeters).
- Missing underlying soft tissue in an area exceeding six square inches (39 square centimeters).
- Skin that is indurated and inflexible in an area exceeding six square inches (39 square centimeters).
The dimensions in that list are part of DC 7800's definitions. A note to the code also tells VA to consider unretouched color photographs when applying its criteria. For a comparison with this code, a description such as "scar present" omits the measurements and other findings the listed characteristics call for. The schedule separately addresses disabling effects associated with individual head, face, or neck scars, including pain, instability, and residual muscle or nerve injury.
DC 7804 instead counts scars that are unstable or painful. It does not restrict the scar's location to the head, face, or neck. The code sets out these tiers:
| Rating | Unstable or painful scars |
|---|---|
| 30% | Five or more. |
| 20% | Three or four. |
| 10% | One or two. |
Note 1 to DC 7804 defines an unstable scar as one with frequent loss of its skin covering for any reason. Note 2 says to add 10 percent to the evaluation based on the total number of unstable or painful scars if one or more scars are both unstable and painful. Note 3 states: "Scars evaluated under diagnostic codes 7800, 7801, 7802, or 7805 may also receive an evaluation under this diagnostic code, when applicable". The notes set out distinct criteria for scar count and for a scar that meets both descriptions.
38 CFR 4.118(b) states: "Two or more skin conditions may be combined in accordance with 4.25 only if separate areas of skin are involved. If two or more skin conditions involve the same area of skin, then only the highest evaluation shall be used." 38 CFR 4.25 explains that separate disability evaluations are combined and that conversion to the nearest degree divisible by 10 occurs once, at the end. Read the same-area rule and the quoted DC 7804 note as written. Neither passage alone predicts how VA would evaluate a particular set of findings.
DC 7828 lists criteria for acne, including deep acne and superficial acne, and provides a disfigurement-or-scars instruction based on the predominant disability. It is another listed code you can distinguish from the skin formula and scar codes. Its presence in the schedule does not establish that PFB is acne or that VA selects DC 7828 for PFB. For the listed scar criteria in more detail, see scar VA ratings under DC 7800-7805.
What Medical Reviews Say PFB Is
A review in Clinical and Experimental Dermatology describes PFB as a chronic inflammatory condition with papules and pustules around hair follicles, primarily in the beard and neck area. A review in Journal of Drugs in Dermatology also calls it razor bumps and describes possible hyperpigmentation and scarring. These are medical descriptions. They are not VA rating criteria.
A review in Clinical, Cosmetic and Investigational Dermatology explains that shaving or plucking can trigger inflammation when sharp growing hair tips penetrate nearby skin. It describes clinical diagnosis and notes that changes in skin pigmentation and scars can follow PFB. The medical terms help you identify what a clinician has documented. The rating schedule supplies the separate rules for lesion extent, treatment, disfigurement, and scars.
When reading a medical record, keep the description of active follicle inflammation separate from any description of lasting skin changes. A note about papules or pustules describes the inflammatory condition. A note about pigmentation or a scar describes another finding that may be relevant to a listed criterion. The reviews do not assign a VA diagnostic code or percentage to either finding.
Our Takeaway
38 CFR 4.118 does not list PFB by name, so there is no single percentage to read from a PFB entry. Sections 4.20 and 4.27 provide the rules for an analogous, built-up code when a condition is unlisted. The relevant comparison depends on documented extent, treatment, and any disfigurement or scarring. Section 4.118(b) limits evaluations for skin conditions in the same area as quoted above. This reading would change if VA amended the schedule to add PFB, and the applicable comparison changes if VA selects a different analogous code for a given record.
If separate disability evaluations are at issue, read how VA combines ratings alongside 38 CFR 4.25. If you are preparing for a compensation and pension (C&P) examination, read the C&P exam tips.
For your pseudofolliculitis barbae VA rating question, compare the code and findings in any VA decision letter with the criteria in 38 CFR 4.118 before deciding what to ask VA to review.
This page is general information, not legal or financial advice. Verify your own rating and benefits with the VA or a VA-accredited representative before you rely on it.